10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001683168-19-003653`
Period End Date	20190930
Filing Date	20191114
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	xbio-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 57 Income Statement 48 Cash Flow Statement 63 Stockholders Equity 43

Balance Sheet 57 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Cash	`Cash`	$12.04M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.66M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	810,856.00	shares	Point-in-time
Cash	`Cash`	$571.61K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	783,865.00	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	5.63M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$555.86K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$876.82K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.19M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.96K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.59K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$705.66K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$709.11K	USD	Point-in-time
Total assets	`Assets`	$14.43M	USD	Point-in-time
Total assets	`Assets`	$22.88M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$934.15K	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherLiabilitiesCurrent`	$665.64K	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherLiabilitiesCurrent`	$538.73K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.60M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.62M	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of September 30, 2019 and December 31, 2018; 5,660,481 and 810,856 shares issued as of September 30, 2019 and December 31, 2018, respectively; 5,633,490 and 783,865 shares outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$811.00	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of September 30, 2019 and December 31, 2018; 5,660,481 and 810,856 shares issued as of September 30, 2019 and December 31, 2018, respectively; 5,633,490 and 783,865 shares outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$5.66K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$188.12M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$168.17M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-164.84M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-153.23M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.78M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$18.26M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.39M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.43M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$22.88M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.37M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.47M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$735.88K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.52M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.27M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.14M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.08M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.90M	USD	3 Qtrs
Goodwill impairment	`GoodwillAndIntangibleAssetImpairment`	$3.28M	USD	3 Qtrs
Goodwill impairment	`GoodwillAndIntangibleAssetImpairment`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillAndIntangibleAssetImpairment`	$3.28M	USD	1 Quarter
Goodwill impairment	`GoodwillAndIntangibleAssetImpairment`	-	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-11.65M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.81M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-8.95M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.64M	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-223.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-24.84K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$267.00	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$2.29K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$46.93K	USD	3 Qtrs
Interest income	`InterestIncomeExpenseNet`	$46.62K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$424.00	USD	3 Qtrs
Interest income	`InterestIncomeExpenseNet`	$59.00	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-24.41K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$2.35K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$46.39K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$47.20K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-11.60M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.66M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	3 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$5.28M	USD	3 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$1.40M	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.66M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.81M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.89M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.31M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-7.58	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-2.31	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-9.07	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-2.67	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.86M	shares	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	746,629.00	shares	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.86M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	783,865.00	shares	1 Quarter

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-11.60M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.66M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Acquired in-process research and development	`PaymentsToAcquireInProcessResearchAndDevelopment`	$3.03M	USD	3 Qtrs
Acquired in-process research and development	`PaymentsToAcquireInProcessResearchAndDevelopment`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$3.28M	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Depreciation	`Depreciation`	$12.54K	USD	3 Qtrs
Depreciation	`Depreciation`	$1.00K	USD	1 Quarter
Depreciation	`Depreciation`	$3.37K	USD	3 Qtrs
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	-	USD	3 Qtrs
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	$16.63K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$2.00K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$15.44K	USD	3 Qtrs
Share-based expense	`ShareBasedCompensation`	$1.12M	USD	3 Qtrs
Share-based expense	`ShareBasedCompensation`	$683.10K	USD	3 Qtrs
Issuance of warrants in connection with reverse stock split	`IssuanceOfWarrantsInConnectionWithReverseStockSplit`	-	USD	3 Qtrs
Issuance of warrants in connection with reverse stock split	`IssuanceOfWarrantsInConnectionWithReverseStockSplit`	$63.54K	USD	3 Qtrs
Vendor share-based expense	`VendorShareBasedCompensation`	$52.28K	USD	3 Qtrs
Vendor share-based expense	`VendorShareBasedCompensation`	$47.43K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$310.24K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$297.71K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-623.99K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$54.17K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.72M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.42M	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00K	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$22.50K	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.00K	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$22.50K	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants in public offering	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants in public offering	`ProceedsFromIssuanceOrSaleOfEquity`	$13.42M	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants in registered direct offering	`ProceedsFromIssuanceOrSaleOfEquity2`	-	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants in registered direct offering	`ProceedsFromIssuanceOrSaleOfEquity2`	$2.70M	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$5.01K	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.48M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.13M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.48M	USD	3 Qtrs
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-3.92M	USD	3 Qtrs
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$11.41M	USD	3 Qtrs
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.68M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.04M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.68M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.04M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.00	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$599.00	USD	3 Qtrs
Right of use asset acquired in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$43.33K	USD	3 Qtrs
Right of use asset acquired in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	3 Qtrs
Issuance of common stock to vendor	`IssuanceOfCommonStockToVendor`	-	USD	3 Qtrs
Issuance of common stock to vendor	`IssuanceOfCommonStockToVendor`	$7.00	USD	3 Qtrs
Issuance of common stock to acquire in-process research and development	`IssuanceOfCommonStockToAcquireInprocessResearchAndDevelopment`	-	USD	3 Qtrs
Issuance of common stock to acquire in-process research and development	`IssuanceOfCommonStockToAcquireInprocessResearchAndDevelopment`	$3.03M	USD	3 Qtrs
Issuance of common stock to adjust for Reverse Stock Split	`IssuanceOfCommonStockToAdjustForReverseStockSplit`	$1.00	USD	3 Qtrs
Issuance of common stock to adjust for Reverse Stock Split	`IssuanceOfCommonStockToAdjustForReverseStockSplit`	-	USD	3 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$1.89K	USD	3 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	-	USD	3 Qtrs
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	-	USD	3 Qtrs
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$316.00	USD	3 Qtrs

Stockholders Equity 43 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$12.78M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.26M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$10.39M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$11.30M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time
Exercise of warrants, value	`StockIssuedForExerciseOfWarrantsValue`	$1.48M	USD	3 Qtrs
Issuance of common stock and warrants in registered direct offering, net of issuance costs, value	`StockIssuedDuringPeriodValueNewIssues`	$2.70M	USD	3 Qtrs
Issuance of common stock and warrants in public offering, net of issuance costs, value	`IssuanceOfCommonStockAndWarrantsInPublicOfferingNetOfIssuanceCostsValue`	$13.42M	USD	3 Qtrs
Issuance of common stock and warrants in public offering, net of issuance costs, value	`IssuanceOfCommonStockAndWarrantsInPublicOfferingNetOfIssuanceCostsValue`	$13.42M	USD	1 Quarter
Issuance of common stock in connection with purchase of in-process research and development, value	`IssuanceOfCommonStockInConnectionWithPurchaseOfInprocessResearchAndDevelopmentValue`	$3.03M	USD	1 Quarter
Issuance of common stock in connection with purchase of in-process research and development, value	`IssuanceOfCommonStockInConnectionWithPurchaseOfInprocessResearchAndDevelopmentValue`	$3.03M	USD	3 Qtrs
Exercise of pre-funded warrant, value	`ExerciseOfPrefundedWarrantValue`	$4.50K	USD	1 Quarter
Exercise of pre-funded warrant, value	`ExerciseOfPrefundedWarrantValue`	$5.01K	USD	3 Qtrs
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	3 Qtrs
Issuance of common stock to vendor, value	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	3 Qtrs
Issuance of warrants in connection with reverse stock split, value	`IssuanceOfWarrantsInConnectionWithReverseStockSplitValue`	$63.54K	USD	1 Quarter
Issuance of warrants in connection with reverse stock split, value	`IssuanceOfWarrantsInConnectionWithReverseStockSplitValue`	$63.54K	USD	3 Qtrs
Issuance of common stock to adjust for reverse split rounding, value	`StockIssuedDuringPeriodValueOther`	-	USD	3 Qtrs
Deemed dividend related to Series B Preferred Stock down round provision	`DeemedDividendRelatedToSeriesBPreferredStockDownRoundProvision`	$5.28M	USD	3 Qtrs
Deemed dividend related to Series B Preferred Stock down round provision	`DeemedDividendRelatedToSeriesBPreferredStockDownRoundProvision`	$1.40M	USD	1 Quarter
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	$1.40M	USD	1 Quarter
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	$5.28M	USD	3 Qtrs
Conversion of Series B preferred stock to shares of common stock, value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	3 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$683.10K	USD	3 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.12M	USD	3 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$232.44K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$306.05K	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$47.43K	USD	3 Qtrs
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$52.28K	USD	3 Qtrs
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$17.43K	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$15.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.60M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.66M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$12.78M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.26M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$10.39M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$11.30M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.